Telescope Innovations Corp. (CSE:TELI)

Market Cap	28.69M +40.6%
Revenue (ttm)	6.28M +58.2%
Net Income	-2.43M
EPS	-0.04
Shares Out	80.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,500
Average Volume	60,435
Open	0.3600
Previous Close	0.3700
Day's Range	0.3550 - 0.3600
52-Week Range	0.2300 - 0.6500
Beta	1.57
RSI	45.92
Earnings Date	Apr 21, 2026

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. ...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Henry Dubina
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TELI

Financial Performance

In fiscal year 2025, Telescope Innovations's revenue was 4.78 million, an increase of 12.03% compared to the previous year's 4.27 million. Losses were -1.56 million, 18.1% more than in 2024.